Need to know: Elizabeth Holmes’s Theranos trial set to begin
By 
Aly McDevitt2021-09-07T12:36:00
Elizabeth Holmes’s legacy is on the line, as the long-awaited trial of the disgraced founder and CEO of blood-testing company Theranos begins Wednesday.
Related articles
-
ArticleCarreyrou at TPRM: Theranos warning signs were there, but partners failed to spot them
John Carreyrou explained to third-party risk professionals at CW’s TPRM Virtual Summit that the mistakes made by Theranos’s business partners were entirely preventable—had they done their proper due diligence.
-
ArticleElizabeth Holmes might seek ‘mental disease’ defense at Theranos trial
Elizabeth Holmes, founder and CEO of now-defunct blood testing company Theranos, is exploring the idea of using “mental disease or defect” as part of her defense during her criminal fraud trial, which is set to begin in March.
-
ArticleWells Fargo’s new TPRM head looked to Theranos for lessons
At CW’s Third-Party Risk Management and Oversight Summit, the head of Wells Fargo’s global TPRM group took a few pages out of biotech startup Theranos’ book to shed light on what not to do when building a risk culture.
More from Ethics & Culture
-
Basic PageNestlé CEO dismissed after code of conduct breach
Nestlé dismissed its CEO over an undisclosed relationship with a subordinate, a clear breach of the company’s code of business conduct. The dismissal underscores that no one is exempt from compliance obligations, even top leadership.
-
PremiumColgate-Palmolive CECO Kim Faulkner discusses how ethics is embedded in the company’s strategy
Compliance Week’s Aaron Nicodemus sat down with Kim Faulkner, Chief Ethics & Compliance Officer at Colgate-Palmolive, to discuss the importance of ethics and compliance at the company.
-
AnalysisSimple steps to improve corporate training can have big impact
We all have terrible attention spans. Understanding how people learn can mean the difference between effective compliance training programs or an eye roll.